Intravenous tranexamic acid given at femoral fragility fracture surgery reduces blood transfusion requirements fourfold

HIGHLIGHTS

• who: Matilda F. R. Powell-Bowns from the Specialist Trainee in Trauma and Orthopaedics, Royal Infirmary of Edinburgh, Little France have published the research work: Intravenous Tranexamic Acid Given at Femoral Fragility Fracture Surgery Reduces Blood Transfusion Requirements Fourfold, in the Journal: (JOURNAL)
• what: Though this study has not undertaken a complete costs analysis, the reduction in transfusion requirement associated with TXA use led to an estimated cost saving of -82.54 per patient.
• how: Data were analysed using SPSS version 25.0. Nonparametric data were analysed using the Mann-Whitney U test . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.